Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Coronavirus company news summary – LivePerson and Innova Medical Group collaborate on AI-powered, at-home Covid-19 rapid testing – GetMyDNA’s Covid-19 test home collection kit gets emergency use authorisation

11 Mar 2021 (Last Updated March 11th, 2021 09:50)

LivePerson, a global technology company that develops conversational commerce and artificial intelligence (AI) software, has collaborated with Innova Medical Group to launch BELLA Health, a first-of-its-kind Covid-19 rapid testing solution with AI-enabled instructions to ensure accuracy. The new test is currently being tested in the first, large-scale at-home rapid testing study in the US.

The US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) to GetMyDNA’s Covid-19 Test Home Collection Kit DTC, which is directly available to consumers for both symptomatic and asymptomatic cases without a doctor’s prescription. While negative results of the test will be sent directly to the individual via email, positive results will be delivered through a healthcare provider.

Relay Medical and Fio Corporation, together with its joint venture company Fionet Rapid Response Group, announced that they have executed an agreement to oversee the deployment of the Fionet Pandemic Management Platform for on-site Covid-19 rapid testing at the Toronto Pearson International Airport. The Canadian government has funded this multi-million-dollar programme, restores flights departing from Toronto Pearson by testing staff and passengers.